SMS Lifesciences India consolidated net profit rises 59.80% in the March 2022 quarter

SMS Lifesciences India said it has completed disinvestment of up to 10% stake of Mahi Drugs and is raising fresh equity in Mahi Drugs, on a private placement basis.

SMS Lifesciences India divests 10% stake of wholly-owned subsidiary, Mahi Drugs

Mangalam Drugs and Organics Ltd, Remsons Industries Ltd, Asian Granito India Ltd and SMS Lifesciences India Ltd are among the other gainers in the BSE’s ‘B’ group today, 11 April 2022.

Sandur Manganese & Iron Ores Ltd leads gainers in ‘B’ group

The share touched a 52-week high of Rs 1,022.50 and a 52-week low of Rs 526.95 on 28 October, 2021 and 15 April, 2021, respectively.

SMS Lifesciences shares jump 20% after USFDA issues zero observation for Telangana unit

SMS Lifesciences jumped 15.2% to Rs 909.85 after the drug maker announced that its manufacturing facility located at Sangareddy district in Telangana completed USFDA without any observations.

SMS Lifesciences soars after API Facility completes USFDA Inspection with No Observations

SMS Lifesciences on Friday announced that its manufacturing facility located at Sangareddy district in Telangana completed USFDA without any observations.

SMS Lifesciences API facility completes USFDA inspection with no observations

Check out the stocks that will be in focus during trade today based on recent and latest news developments.

Top stocks in focus: Mold-Tek Packaging, GR Infraprojects, Tamilnadu PetroProducts, Deepak Nitrite, SMS Lifesciences India

According to the agreements, SMS Lifesciences will divest up to 10 per cent shareholding in Mahi Drugs and raise fresh equity in the company through the private placement route.

SMS Lifesciences gains 5% on deal to divest partial stake in Mahi Drugs

The Board has approved raising fresh equity in Mahi Drugs Private Limited, on Private Placement basis, to ChemWerth Inc., USA and its Associates.

SMS Lifesciences India to divest partial stake in Mahi Drugs; Stock dips 1%

Gokul Agro Resources Ltd, Ambition Mica Ltd, Sona BLW Precision Forgings Ltd and Jai Balaji Industries Ltd are among the other gainers in the BSE’s ‘B’ group today, 28 October 2021.

SMS Lifesciences India Ltd leads gainers in ‘B’ group

Venkata Chaitanya Gopineedi has been appointed as Director in the Board of the Mahi Drugs in the Executive category.

SMS Lifesciences updates on board composition of subsidiary company; Stock trades flat

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of organic and inorganic chemicals,pharmaceuticals

SMS Lifesciences India Ltd